Our high-security, climate-controlled facility is just outside Belfast, surrounded by open countryside, minimising any impact on neighbours but enabling fast, easy access to distribution networks.

We aim to lead the prescription cannabis industry, researching and developing specialist cultivars to treat a variety of conditions, mainly as an alternative to harmful opioid painkillers but also for diseases such as multiple sclerosis, Crohn’s and gynaecological conditions.

Our cannabis will be available on prescription from doctors as premium quality flower. We expect to start commercial production in early 2025.